X-Chem
在场
高管
查看带有其 11 名主要高管的组织结构图
X-Chem 搜索最多的简介
- Karen Lackey, Chief Executive Officer
- Noor Shaker, Senior Vice President and General Manager, London
- Matthew Clark, President and Chief Scientific Officer
高管在X-Chem变化
- Karen Lackey 曾任 Chief Scientific Officer, 现升职为 Chief Executive Officer (新闻发布的2024一月5号).
- Karen Lackey已作为Chief Scientific Officer加入公司 (新闻发布的2023八月10号).
创建提醒
跟踪 X-Chem 的高管变动
生物技术
GHO Capital 拥有 2,276 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Adaptive Phage Therapeutics (美国(美洲))。
Popular M&A news in 生物技术
- Bruker has announced the acquisition of NanoString Technologies (公布2024四月18号).
- Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences (公布2024四月16号).
- Nurix Therapeutics 刚刚宣布为 175 筹款数百万美元。 (公布2024四月13号).
生物技术 行业的其他推荐联系人
消息
X-Chem 的最新新闻稿
- Fibrolamellar Cancer Foundation: New research collaboration with X‑Chem | X-Chem
- X‑Chem Transitions Executives into New Roles, Appoints New Chief Executive Officer | X-Chem
- 2024 | X-Chem
- X-Chem Announces Achievement of Collaboration Milestone | X-Chem
- Rumi Scientific Announces Partnership with X-Chem for Development of Lead Candidate in Huntington’s Disease | X-Chem
- X-Chem Appoints Chief Scientific Officer and Chief Financial Officer | X-Chem
- 2023 | X-Chem
- NEWS & PUBS - X-CHEM
- news Archives - X-CHEM
- NEWS & PUBS - X-CHEM
- View more press releases Close
通过电子邮件
